Literature DB >> 15596243

Localization of cyclooxygenase-2 induced following traumatic spinal cord injury.

Kayo Adachi1, Yu Yimin, Kotaro Satake, Yukihiro Matsuyama, Naoki Ishiguro, Makoto Sawada, Yoko Hirata, Kazutoshi Kiuchi.   

Abstract

OBJECTIVE: Up-regulation of cyclooxygenase-2 (COX-2), a key enzyme in the synthesis of prostaglandins (PGs), is postulated to be involved in pathological processes of acute spinal cord injury (SCI). In the present study, we sought to clarify temporal and spatial expression patterns of the COX-2 gene induced in the spinal cord after traumatic insults using a weight-drop technique.
RESULTS: Reverse transcriptase-polymerase chain reaction (RT-PCR) revealed that COX-2 transcription in the spinal cord began to increase within 30 min, peaked at 3 h after injury. Western blotting analysis indicated that the deglycosylated COX-2 protein significantly increased 6 h after injury. Double-immunofluorescent staining analysis showed that COX-2 immunoreactivity was present only in endothelial cells of blood vessels, but not in neurons, astrocytes, monocytes, macrophages, or microglia 6 h after injury.
CONCLUSIONS: The results suggested that COX-2 gene induction seems not to require any new protein synthesis and that its expression in endothelial cells may be a component of an inflammatory process after traumatic SCI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596243     DOI: 10.1016/j.neures.2004.10.007

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  8 in total

1.  Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.

Authors:  Deirtra A Hunter; Gordon A Barr; Kai-Yvonne Shivers; Nicole Amador; Shirzad Jenab; Charles Inturrisi; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2011-01-31       Impact factor: 3.252

2.  Pharmacokinetics and anti-inflammatory effect of naproxen in rats with acute and subacute spinal cord injury.

Authors:  Arianna Rodríguez-Cal Y Mayor; Gilberto Castañeda-Hernández; Liliana Favari; Angelina Martinez-Cruz; Gabriel Guízar-Sahagún; Leticia Cruz-Antonio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-22       Impact factor: 3.000

3.  Tempol reduces injury area in rat model of spinal cord contusion injury through suppression of iNOS and COX-2 expression.

Authors:  Hong-Hua Quan; Ku-Seong Kang; Yoon-Kyung Sohn; Ming Li
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

4.  Effects of zileuton and montelukast in mouse experimental spinal cord injury.

Authors:  T Genovese; A Rossi; E Mazzon; R Di Paola; C Muià; R Caminiti; P Bramanti; L Sautebin; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

5.  Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury.

Authors:  Kyoung-Jin Min; Hey-Kyeong Jeong; Beomsue Kim; Dong Hoon Hwang; Hae Young Shin; An Tran Nguyen; Jong-Hyeon Kim; Ilo Jou; Byung G Kim; Eun-Hye Joe
Journal:  J Neuroinflammation       Date:  2012-05-25       Impact factor: 8.322

6.  Zafirlukast in combination with pseudohypericin attenuates spinal cord injury and motor function in experimental mice.

Authors:  Xiao-Gang Chen; Fu Hua; Shou-Guo Wang; Yong-Yi Xu; Hai-Tao Yue; Jin Sun
Journal:  Drug Des Devel Ther       Date:  2018-08-01       Impact factor: 4.162

7.  Panax ginseng Improves Functional Recovery after Contusive Spinal Cord Injury by Regulating the Inflammatory Response in Rats: An In Vivo Study.

Authors:  Young Ock Kim; Youngkyung Kim; Koeun Lee; Sae Won Na; Seon Pyo Hong; Mariadhas Valan Arasu; Young Wook Yoon; Junesun Kim
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-15       Impact factor: 2.629

8.  Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles.

Authors:  Jong-Wan Kim; Chinmaya Mahapatra; Jin-Young Hong; Min Soo Kim; Kam W Leong; Hae-Won Kim; Jung Keun Hyun
Journal:  Adv Sci (Weinh)       Date:  2017-07-08       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.